Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04569006 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multi-contrast Versus Multi-sequence Carotid MRI

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date changed from estimate of Apr 1, 2025 to May 22, 2026 Show 7 more changesShow less
    • Trial completed
    • Final enrollment: 14 participants (planned 40)
    • Primary completion date changed from estimate of Apr 1, 2025 to Apr 22, 2025
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description revised
    • Site details revised
  2. Re-verified, no change to tracked fieldsv6
  3. Primary completion date: Nov 2023 to Apr 1, 2025
    • Study completion date: Dec 2023 to Apr 1, 2025
    v5
  4. Start date changed from estimate of Feb 2021 to Apr 8, 2021
    • Site contact updated
    v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 2020 to Feb 2021
    v3
  6. Study title expanded, about 1 wordv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to validate 2 multi-contrast sequences, namely the Multi-contrast ATherosclerosis Characterization (MATCH) and Bright-blood and black-blOOd phase SensiTive (BOOST) inversion recovery sequence for the quantification of atherosclerotic plaque components with conventional multi-sequence MRI and histology.
Trial Details
NCT Number NCT04569006
Lead Sponsor Maastricht University Medical Center
Conditions
(from sponsor)		 Atherosclerosis
Related terms Atherosclerosis
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov